Related Experiment Video
Updated: Oct 18, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host
Thomas Belcher1, Violaine Dubois1, Alex Rivera-Millot1
1Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France.
Abstract:
The highly contagious whooping cough agent Bordetella pertussis has evolved as a human-restricted pathogen from a progenitor which also gave rise to Bordetella parapertussis and Bordetella bronchiseptica. While the latter colonizes a broad range of mammals and is able to survive in the environment, B. pertussis has lost its ability to survive outside its host through massive genome decay. Instead, it has become a highly successful human pathogen by the acquisition of tightly regulated virulence factors and evolutionary adaptation of its metabolism to its particular niche. By the deployment of an arsenal of highly sophisticated virulence factors it overcomes many of the innate immune defenses. It also interferes with vaccine-induced adaptive immunity by various mechanisms. Here, we review data from invitro, human and animal models to illustrate the mechanisms of adaptation to the human respiratory tract and provide evidence of ongoing evolutionary adaptation as a highly successful human pathogen.
Insights
Whooping cough (Bordetella pertussis) evolved from a progenitor species, losing environmental survival but gaining virulence factors. This review details its adaptation to humans and immune evasion strategies.
Area of Science:
- Microbiology
- Evolutionary Biology
- Immunology
Background:
- Bordetella pertussis is a highly contagious human pathogen responsible for whooping cough.
- It evolved from a progenitor species that also gave rise to Bordetella parapertussis and Bordetella bronchiseptica.
- Unlike its relatives, B. pertussis has lost environmental survival capabilities due to genome decay.
Purpose of the Study:
- To review the evolutionary adaptation mechanisms of Bordetella pertussis to the human respiratory tract.
- To illustrate how B. pertussis overcomes host innate and vaccine-induced adaptive immunity.
- To provide evidence of ongoing evolutionary adaptation in this successful human pathogen.
Main Methods:
- Review of in vitro studies.
- Analysis of data from human clinical cases.
- Examination of findings from animal models of pertussis.
Main Results:
- B. pertussis has acquired sophisticated virulence factors and adapted its metabolism for human colonization.
- The pathogen effectively evades innate immune defenses.
- Mechanisms interfering with vaccine-induced adaptive immunity have been identified.
Conclusions:
- Bordetella pertussis demonstrates remarkable evolutionary adaptation to thrive as a human-specific pathogen.
- Its success is attributed to genome decay, virulence factor acquisition, and immune evasion strategies.
- Ongoing evolution suggests continued adaptation to the human host and vaccination pressures.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transduction
Bacterial Phylum Spirochaetes
Bacterial Phylum Chlamydiae
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

